386,301
Participants
Start Date
December 1, 2021
Primary Completion Date
September 30, 2023
Study Completion Date
July 22, 2025
Glucagon like peptide 1 receptor agonist
Patients in the data who filled a glucagon-like peptide-1 receptor agonist medication
Sodium-glucose cotransporter 2 inhibitor
Patients in the data who filled a sodium-glucose cotransporter 2 inhibitor
Dipeptidyl Peptidase 4 Inhibitor
Patients in the data who filled a dipeptidyl peptidase-4 inhibitor
Sulfonylurea
Patients in the data who filled a sulfonylurea
Mayo Clinic Rochester, Rochester
Lead Sponsor
Patient-Centered Outcomes Research Institute
OTHER
Mayo Clinic
OTHER